COP — CompuGroup Medical SE & Co KgaA Income Statement
0.000.00%
- €1.14bn
- €1.91bn
- €1.15bn
- 79
- 35
- 69
- 68
Annual income statement for CompuGroup Medical SE & Co KgaA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 837 | 1,025 | 1,130 | 1,188 | 1,154 |
Cost of Revenue | |||||
Gross Profit | 713 | 871 | 958 | 1,005 | 967 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 715 | 923 | 1,031 | 1,074 | 1,047 |
Operating Profit | 122 | 103 | 98.8 | 113 | 107 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 110 | 97.9 | 107 | 72.7 | 61.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | 73.4 | 69 | 74.1 | 46.9 | 34.8 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 73.2 | 69 | 73.4 | 45.9 | 34.6 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 73.2 | 69 | 73.4 | 45.9 | 34.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.22 | 1.23 | 1.67 | 1.39 | 1.53 |
Dividends per Share |